Aligos Therapeutics Funding: $225M Raised, Series B (2020)

Aligos Therapeutics funding overview

Aligos Therapeutics is based in South San Francisco. Aligos Therapeutics has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Aligos Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Wellington Management Company, Janus Henderson Investor, Boxer Capital of Tavistock Group, Cormorant Asset Management, Pivotal bioVenture Partners, Logos Capital and 4 others. 10 distinct backers are named across the disclosed rounds.

Aligos Therapeutics at a glance

Total raised: $225M
Latest round: Series B
Latest round date: January 2020
Headquarters: South San Francisco
Notable investors: Wellington Management Company, Janus Henderson Investor, Boxer Capital of Tavistock Group, Cormorant Asset Management, Pivotal bioVenture Partners, Logos Capital, Vivo Capital, Versant Ventures

Frequently asked about Aligos Therapeutics funding

How much has Aligos Therapeutics raised?: Aligos Therapeutics has raised $225M in total disclosed funding across the rounds on record.
Who has invested in Aligos Therapeutics?: Wellington Management Company, Janus Henderson Investor, Boxer Capital of Tavistock Group, Cormorant Asset Management, Pivotal bioVenture Partners, Logos Capital are named among the investors backing Aligos Therapeutics.
What was the latest Aligos Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2020.
Where is Aligos Therapeutics based?: Aligos Therapeutics is based in South San Francisco.
When did Aligos Therapeutics last raise?: The last disclosed Aligos Therapeutics round closed in January 2020 at Series B.

Round data for Aligos Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in South San Francisco and backer lists below.

Aligos Therapeutics Funding: $225M Raised, Series B (2020)

Aligos Therapeutics funding overview

Aligos Therapeutics at a glance

Frequently asked about Aligos Therapeutics funding

Companies related to Aligos Therapeutics (31)

Browse related funding lists (6)